Metrika

  • citati u SCIndeksu: [2]
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:4
  • preuzimanja u poslednjih 30 dana:1

Sadržaj

članak: 8 od 9  
Back povratak na rezultate
2007, vol. 64, br. 1, str. 45-51
Metabolički sindrom X ili sindrom insulinske rezistencije
aUniverzitet u Beogradu, Medicinski fakultet, Institut za kardiovaskularne bolesti 'Dedinje'
bUniverzitet u Beogradu, Medicinski fakultet, KBC 'Bežanijska kosa'
cAgencija za lekove i pomoćna sredstva Republike Srbije, Beograd

e-adresanikolicd@beotel.yu
Sažetak
Članak ne sadrži sažetak.
Reference
Alberti, K.G.M.M., Zimmet, P., Shaw, J. (2006) Metabolic syndrome: A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, Vol. 23, No. 5, pp. 469-80
American College of Endocrinology (2003) Insulin resistance syndrome: Position Statement. Endocr Pract, 9(Suppl 2), str. 9-21
American Diabetes Association (2003) Standards of medical care for patients with diabetes mellitus. Diabetes Care, 26 Suppl 1 S33-50
Balkau, B., Charles, M.A. (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med, 16(5): 442-3
Bjorntorp, P. (1998) Etiology of the metabolic syndrome. u: Bray G.A., Bouchard C., James W.P.T. [ur.] Handbook of obesity, New York-Basel: Marcel Dekker, str. 573-600
Bray, G.A., Bellanger, T. (2006) Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine, 29(1), 109-117
Cameron, A.J., Shaw, J.E., Zimmet, P.Z. (2004) The metabolic syndrome: Prevalence in worldwide populations. Endocrinol Metab Clin North Am, 33(2): 351-75, table of contents
Camus, J.P. (1966) Gout, diabetes, hyperlipemia: A metabolic trisyndrome. Rev Rhum Mal Osteoartic, 33(1): 10-4
Carr, M.C., Brunzell, J.D. (2004) Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab, 89(6): 2601-7
Choudhury, J., Sanyal, A.J. (2004) Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis, 8(3): 575-94, ix
de Fronzo, R.A., Ferrannini, E. (1991) Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14(3): 173-94
DECODE Study Group European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med, 161(3): 397-405
DeFronzo, R.A., Cooke, C.R., Andres, R., Faloona, G.R., Davis, P.J. (1975) The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest, 55(4): 845-55
Expert Committee Diagnosis Clasification Diabetes Mellitus (2002) American Diabetes Association: Clinical practice recommendations 2002. Diabetes Care, 25 Suppl 1: S1-147
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285(19): 2486-97
Facchini, F., Chen, Y.D., Hollenbeck, C.B., Reaven, G.M. (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA, 266(21): 3008-11
Facchini, F.S., Stoohs, R.A., Reaven, G.M. (1996) Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens, 9(10 Pt 1): 1013-7
Fernandez-Real, J.M., Ricart, W. (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev, 24(3): 278-301
Ford, E.S., Giles, W.H., Dietz, W.H. (2002) Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA, 287(3): 356-9
Haffner, S.M., Valdez, R.A., Hazuda, H.P., Mitchell, B.D., Morales, P.A., Stern, M.P. (1992) Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes, 41(6): 715-22
Haller, H., Hanefeld, M., Naumann, H.J., Kunze, D., Wehner, J. (1967) Statistical studies on the pathogenesis of the fatty liver in diabetics. Z Gesamte Inn Med, 22(2): 41-8
Hanson, R.L., Imperatore, G., Bennett, P.H., Knowler, W.C. (2002) Components of the 'metabolic syndrome' and incidence of type 2 diabetes. Diabetes, 51(10): 3120-7
Hollenbeck, C.B., Johnston, P., Varasteh, B.B., Chen, Y.D., Reaven, G.M. (1991) Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria. Diabete Metab, 17(5): 483-9
Hunt, K.J., Resendez, R.G., Williams, K., Haffner, S.M., Stern, M.P. (2004) National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study. Circulation, 110(10): 1251
Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Lahti, K., Nissen, M., Taskinen, M.R., Groop, L. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4): 683-9
Kaplan, N.M. (1989) The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med, 149(7): 1514-20
Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., Nathan, D.M., Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346(6): 393-403
Kylin, E. (1923) Studien ueber das Hypertonie-Hyperglyka 'mie-Hyperurika' miesyndrom. Zentralblatt fuer Innere Medizin, 44, str. 105-27
Laaksonen, D.E., Lakka, H., Niskanen, L.K., Kaplan, G.A., Salonen, J.T., Lakka, T.A. (2002) Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol, 156(11): 1070-7
Lesniak, W., Kolasinska-Kloch, W. (2003) Do syndromes X, cardiac and metabolic, have any similar characteristics?. Folia Med Cracov, 44(1-2): 59-69
Lorincz, A.M., Sukumar, S. (2006) Molecular links between obesity and breast cancer. Endocrine-Related Cancer, 13(2), 279-292
Matsuda, M., de Fronzo, R.A. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care, 22(9): 1462-70
Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C. (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7): 412-9
Mckeigue, P.M. (1999) Ethnic variation in insulin resistance and risk of type 2 diabetes. u: Reaven G.M., Laws A. [ur.] Insulin Resistance: The Metabolic Syndrome X, Oxford: Blackssell Publishing, p. 19-34
Mclaughlin, T., Abbasi, F., Lamendola, C., Kim, H.S., Reaven, G.M. (2001) Metabolic changes following sibutramine-assisted weight loss in obese individuals: Role of plasma free fatty acids in the insulin resistance of obesity. Metabolism, 50(7): 819-24
Mclaughlin, T., Abbasi, F., Kim, H.S., Lamendola, C., Schaaf, P., Reaven, G. (2001) Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism, 50(7): 795-800
Nestler, J.E. (2003) Insulin resistance syndrome and polycystic ovary syndrome. Endocr Pract, 9 Suppl 2 86-9
Nesto, R.W. (2003) The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med, 4 Suppl 6 S11-8
Neuschwander-Tetri, B.A., Caldwell, S.H. (2003) Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology, 37(5): 1202-19
Pischon, T., Girman, C.J., Hotamisligil, G.S., Rifai, N., Hu, F.B., Rimm, E.B. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 291(14): 1730-7
Reaven, G.M. (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37(12): 1595-607
Reaven, G.M. (2004) Insulin resistance, cardiovascular disease, and the metabolic syndrome: How well do the emperor's clothes fit?. Diabetes Care, 27(4): 1011-2
Ridker, P.M., Buring, J.E., Cook, N.R., Rifai, N. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation, 107(3): 391-7
Robbins, D.C., Andersen, L., Bowsher, R., Chance, R., Dinesen, B., Frank, B., Gingerich, R., Goldstein, D., Widemeyer, H.M., Haffner, S., Hales, C.N., Jarett, L., Polonsky, K., Porte, D., Skyler, J., Webb, G., Gallagher, K. (1996) Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes, 45(2): 242-56
Rutter, M.K., Meigs, J.B., Sullivan, L.M., Agostino, R.D.B., Wilson, P.W.F. (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation, 110(4): 380-5
Scott, L.K. (2006) Insulin resistance syndrome in children. Pediatr Nurs, 32(2): 119−24, 143
Singhal, A. (2006) Nutritional interventions in infancy and childhood for prevention of atherosclerosis and the metabolic syndrome. Nestle Nutr Workshop Ser Pediatr Program, 57): 15−25
Stuhlinger, M.C., Abbasi, F., Chu, J.W., Lamendola, C., McLaughlin, T.L., Cooke, J.P., Reaven, G.M., Tsao, P.S. (2002) Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA, 287(11): 1420-6
Sutherland, J.P., McKinley, B., Eckel, R.H. (2004) The metabolic syndrome and inflammation. Metabolic Syndrome and Related Disorders, 2(2), 82-104
Trayhurn, P., Wood, S.I. (2004) Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr, 92(3): 347-55
Ugrešić, N. (2005) A guide for pharmacotherapy. Beograd: Agencija za lekove i medicinska sredstva Srbije
Vague, J. (1996) Sexual differentiation: A determinant factor of the forms of obesity. 1947. Obes Res, 4(2): 201-3
Vague, J. (1996) The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. 1956. Obes Res, 4(2): 204-12
Valle, T.T., Lindstrom, J., Eriksson, J.G., Uusitupa, M., Tuomilehto, J. (2001) Type 2 diabetes can be prevented by life style changes. Duodecim, 117(15): 1517-8
Wallace, T.M., Levy, J.C., Matthews, D.R. (2004) Use and abuse of HOMA modeling. Diabetes Care, 27(6): 1487-95
World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: Department of Noncommunicable Disease Surveillance
Yeni-Komshian, H., Carantoni, M., Abbasi, F., Reaven, G.M. (2000) Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care, 23(2): 171-5
Zavaroni, I., Mazza, S., Dall, A.E., Gasparini, P., Passeri, M., Reaven, G.M. (1992) Prevalence of hyperinsulinaemia in patients with high blood pressure. Journal of internal medicine, Vol. 231, No. 3, pp. 235-40
 

O članku

jezik rada: srpski
vrsta rada: saopštenje
DOI: 10.2298/VSP0701045N
objavljen u SCIndeksu: 03.12.2007.

Povezani članci

Med gl Spec bol štit Zlatibor (2016)
Uticaj prisustva metaboličkog sindroma na nalaz testa fizičkim opterećenjem
Crnčević Nenad

Med gl Spec bol štit Zlatibor (2016)
Učestalost metaboličkog sindroma kod gojaznih učesnika programa Čigota
Crnčević Nenad

Med gl Spec bol štit Zlatibor (2010)
Metabolički sindrom, diabetes mellitus tip 2 i kardiovaskularni poremećaji
Micić Dragan, i dr.

prikaži sve [119]